Barely Significant
← all excerpts

Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study.

Clin Exp Vaccine Res · 2026 · PMC13144742 · PMID 42099696

Europe PMCDOI
1
hedged sentence
0.0560
closest p · 1.1× alpha
0.0560
boldest claim

The sentences

marginally significantp=0.056so close (0.05 < p ≤ 0.1)
The difference between the Canvac R® singles dose and the Nobivac® Rabies vaccine groups was also marginally significant with p=0.056.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.